| 查看: 285 | 回复: 1 | ||
zhongandxu银虫 (初入文坛)
|
[求助]
求大神解谱已有1人参与
|
|
碳谱数据如下: 181.67 152.25 149.11 144.96 135.96 135.48 134.74 133.05 131.27 129.09 128.36 127.53 125.15 123.14 106.58 103.87 103.84 40.47 40.40 40.30 40.23 40.14 39.97 39.80 39.63 39.47 溶剂是DMSO |
» 猜你喜欢
心脉受损
已经有6人回复
博士申请都是内定的吗?
已经有8人回复
博士读完未来一定会好吗
已经有32人回复
之前让一硕士生水了7个发明专利,现在这7个获批发明专利的维护费可从哪儿支出哈?
已经有8人回复
读博
已经有5人回复
投稿精细化工
已经有4人回复
高职单位投计算机相关的北核或SCI四区期刊推荐,求支招!
已经有4人回复
导师想让我从独立一作变成了共一第一
已经有9人回复
Springer期刊投稿求助
已经有4人回复
liphie
银虫 (小有名气)
- 应助: 31 (小学生)
- 金币: 719.9
- 散金: 70
- 帖子: 239
- 在线: 71.9小时
- 虫号: 1398320
- 注册: 2011-09-11
- 专业: 心脑血管药物药理
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与,应助指数 +1
zhongandxu: 金币+30, ★有帮助 2014-03-24 15:19:39
感谢参与,应助指数 +1
zhongandxu: 金币+30, ★有帮助 2014-03-24 15:19:39
|
查询结果:共查到9个化合物(查询结果仅供参考) 1 . Compound QNE 相似度:56% Tetrahedron 2012 68 8371-8375 A novel copper(Ⅱ) complex-based fluorescence probe for nitric oxide detecting and imaging Xiaoyue Hu, Xiaolin Zhang, Honglei Song, Cheng He, Yongming Bao, Qin Tang, Chunying Duan Structure 13C NMR Structure & 13C NMR 碳谱模拟图 2 . 6-Chloro-2-methoxy-N-(3,4,5-trimethoxyphenyl)acridin-9-amine C23H22ClN2O4 相似度:55.5% Bioorganic & Medicinal Chemistry 2011 19 3312-3319 Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors Xudong Luan,Chunmei Gao, Nannan Zhang , Yuzong Chen, Qinsheng Sun ,Chunyan Tan , Hongxia Liu , Yibao Jin, Yuyang Jiang Structure 13C NMR Structure & 13C NMR 碳谱模拟图 3 . 2-[6-Chloro-3-(3-hydroxypropylamino)-1,1-dioxo-1,4,2-benzodithiazin-7-yl]-3-phenyl-4(3H)-quinazolinone C24H19ClN4O4S2 相似度:52% Archiv der Pharmazie 2008 341 485-490 Synthesis and Cytotoxicity Testing of Novel 2-(3-Substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones Elzbieta Pomarnacka, Magdalena Maruszak, Karolina Langowska, Przemyslaw Reszka and Patrick J. Bednarski Structure 13C NMR Structure & 13C NMR 碳谱模拟图 4 . 2-{6-Chloro-1,1-dioxo-3-[(pyridin-3-ylmethyl)amino]-1,4,2-benzodithiazin-7-yl}-3-phenyl-4(3H)-quinazolinone C27H18ClN5O3S2 相似度:52% Archiv der Pharmazie 2008 341 485-490 Synthesis and Cytotoxicity Testing of Novel 2-(3-Substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones Elzbieta Pomarnacka, Magdalena Maruszak, Karolina Langowska, Przemyslaw Reszka and Patrick J. Bednarski Structure 13C NMR Structure & 13C NMR 碳谱模拟图 5 . compound 5 C65H44BF2N7O2Zn 相似度:52% Tetrahedron 2012 68 830-840 Synthesis of non-covalent BODIPY–metalloporphyrin dyads and triads Tamanna K. Khan, Mangalampalli Ravikanth Structure 13C NMR Structure & 13C NMR 碳谱模拟图 6 . methyl 4-{3-[4-(pyridin-3-yl)pyrimidin-2-yl-amino]phenylaminomethyl}benzoate C24H21N5O2 相似度:52% Russian Journal of Organic Chemistry 2009 45 1070-1078 Reductive transformations of Schiff bases in the synthesis of functionally substituted heteroaromatic amines Zh. V. Ignatovich, A. P. Kadutskii, E. V. Koroleva, A. V. Baranovskii and K. N. Gusak Structure 13C NMR Structure & 13C NMR 碳谱模拟图 7 . cis-N-2-(2''-bromophenyl)-4-oxo-3,4,6,7-tetrahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-benzamide C28H25BrN2O4 相似度:52% Tetrahedron 2012 68 2864-2875 Synthesis of benzoindoloquinolizines via a Cu(I)-mediated C–N bond formation Rattana Worayuthakarn, Prattya Nealmongkol, Somsak Ruchirawat, Nopporn Thasana Structure 13C NMR Structure & 13C NMR 碳谱模拟图 8 . 6-Bromo-8-hydroxy-3-benzoylcoumarin C16H9BrO4 相似度:52% Bioorganic & Medicinal Chemistry Letters 2011 21 4224-4227 MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins Maria João Matos, Saleta Vazquez-Rodriguez, Eugenio Uriarte, Lourdes Santana, Dolores Viña Structure 13C NMR Structure & 13C NMR 碳谱模拟图 9 . 6-(4-Hydroxyphenyl)-4-(10H-phenothiazin-2-yl)-1-phenylpyrimidine-2(1H)-thione C28H19N3S2O 相似度:52% Journal of Heterocyclic Chemistry 2012 49 1004-1008 Synthesis and Antimicrobial Activity of 4-(10H-Phenothiazin-2-yl)-pyrimidin-2(1H)-one/thione Derivatives Tanaji N. Bansode and Gangadhar A. Meshram Structure 13C NMR Structure & 13C NMR 碳谱模拟图 |
2楼2014-03-21 17:41:11













回复此楼